425: Kenvue Supplements Merger Proxy Amid Shareholder Lawsuits

Kenvue Inc. has filed a supplement to its joint proxy statement/prospectus for the proposed merger with Kimberly-Clark Corporation, addressing shareholder litigation and providing updated financial analysis details.

Summary

• Kenvue Inc. filed a Form 8-K to supplement its Joint Proxy Statement/Prospectus related to the proposed merger with Kimberly-Clark Corporation (K-C).
• The supplement addresses multiple shareholder lawsuits filed against Kenvue and its board, and K-C and its board, alleging material omissions in previous disclosures.
• The lawsuits generally seek to enjoin the stockholder votes or the mergers until corrective disclosures are made, and seek attorneys' fees and other litigation costs.
• Kenvue is providing these supplemental disclosures voluntarily to avoid delaying the mergers and minimize litigation expense, without admitting legal necessity or materiality.
• The Kenvue board continues to unanimously recommend that Kenvue stockholders vote FOR the Kenvue merger proposal, FOR the Kenvue advisory compensation proposal, and FOR the Kenvue adjournment proposal.
• Updated financial analysis details from Centerview Partners LLC and Goldman Sachs & Co. LLC are included, revising figures for implied enterprise values, equity values, and per-share values for both Kenvue and K-C, as well as the pro forma combined company.
• Revised prospective financial information (revenue, Adjusted EBITDA, Unlevered Free Cash Flow) for K-C standalone, Kenvue standalone, K-C management adjusted Kenvue, and Kenvue management adjusted K-C projections for fiscal years 2025-2030 are provided.

Sentiment

Score: 5

Explanation: The filing is a procedural update to address shareholder litigation related to a pending merger. While the litigation itself introduces a negative element, the company's proactive response to provide supplemental disclosures is a neutral action aimed at keeping the merger on track. The updated financial projections do not present a significant shift in the overall outlook, maintaining a neutral sentiment.

Positives

• The Kenvue board unanimously recommends the merger, indicating continued confidence in the transaction.
• Kenvue is proactively addressing shareholder concerns by providing supplemental disclosures to avoid potential delays and minimize litigation expenses.

Negatives

• Multiple shareholder lawsuits have been filed against Kenvue and its board, and K-C's board, alleging material omissions in merger disclosures.
• The lawsuits generally seek to enjoin the merger or stockholder vote, which could delay or complicate the transaction.
• Demand letters from shareholders also allege material omissions in the disclosures.

Risks

• Risk of delaying or adversely affecting the consummation of the Mergers due to ongoing litigation.
• Potential for additional similar complaints or amended complaints to be filed.
• Uncertainty of the underlying assumptions and estimates used in forward-looking statements and financial projections.
• Risks related to the occurrence of any event, change, or other circumstance that could lead to the termination of the Merger Agreement, including circumstances requiring a party to pay a termination fee.
• Risk that the conditions to the completion of the proposed transaction (including stockholder and regulatory approvals) are not satisfied in a timely manner or at all.
• Possibility that competing offers or transaction proposals may be made.
• Risks arising from the integration of the K-C and Kenvue businesses.
• Risk that the anticipated benefits and synergies of the proposed transaction may not be realized when expected or at all.
• Risk of unexpected costs or expenses resulting from the proposed transaction.
• Risk of litigation related to the proposed transaction, including resulting expense or delay.
• Risks related to disruption to ongoing business operations and diversion of management's time as a result of the proposed transaction.
• Risk that the proposed transaction may have an adverse effect on the ability of K-C and Kenvue to retain key personnel, customers, and suppliers.
• Risk that the credit ratings of the combined company decline following the proposed transaction.
• Risk that the announcement or consummation of the proposed transaction has a negative effect on the market price of the capital stock of K-C and Kenvue or on their operating results.
• Risk of product liability litigation or government or regulatory action, including related to product liability claims.
• Risk of product efficacy or safety concerns resulting in product recalls or regulatory action.
• Risks relating to inflation and other economic factors, such as interest rate and currency exchange rate fluctuations.
• Risks from government trade or similar regulatory actions (including current and potential trade and tariff actions and other constraints on trade affecting operating countries).
• Risks from natural disasters, acts of war, terrorism, catastrophes, pandemics, epidemics, or other disease outbreaks.
• Risks related to the prices and availability of raw materials, manufacturing difficulties or delays, or supply chain disruptions.
• Disruptions in the capital and credit markets, and counterparty defaults (including customers, suppliers, and financial institutions).
• Impairment of goodwill and intangible assets and projections of operating results affecting impairment testing.
• Changes in customer preferences, severe weather conditions, regional instabilities, and hostilities.
• Potential competitive pressures on selling prices for K-C and Kenvue products.
• Energy costs, general economic and political conditions globally and in the markets where K-C and Kenvue do business.
• Ability to maintain key customer relationships, competition (including technological advances, new products, and intellectual property attained by competitors).
• Challenges inherent in new product research and development, and uncertainty of commercial success for new and existing products and digital capabilities.
• Challenges to intellectual property protections, including counterfeiting.
• Ability of K-C and Kenvue to successfully execute business development strategy and other strategic plans.
• Changes to applicable laws and regulations and other requirements imposed by stakeholders, as well as changes in behavior and spending patterns of consumers.

Future Outlook

The filing primarily provides supplemental disclosures for a pending merger and updated financial analyses. It reiterates the Kenvue board's unanimous recommendation for the merger. Forward-looking statements are general cautionary language about the merger's anticipated benefits, integration risks, and market conditions, rather than new guidance on operational performance.

Management Comments

• "The Kenvue board continues to unanimously recommend that Kenvue stockholders vote FOR the Kenvue merger proposal, FOR the Kenvue advisory compensation proposal and FOR the Kenvue adjournment proposal."

Industry Context

The proposed merger between Kenvue and Kimberly-Clark represents a significant consolidation within the consumer health and personal care sectors. This strategic move aims to create a stronger combined entity with a broader product portfolio, potentially enhancing market share and competitive positioning against industry giants such as Procter & Gamble, Colgate-Palmolive, and Unilever. The ongoing strategic review process and subsequent merger agreement reflect a broader industry trend towards optimizing portfolios and seeking economies of scale in mature consumer goods markets.

Comparison to Industry Standards

• Centerview's Selected Public Comparable Companies Analysis indicates Kenvue's Implied Enterprise Value / Estimated 2026 EBITDA at 9.9x, which is below the median of 13.6x for a peer group including Church & Dwight (15.5x), Colgate-Palmolive (13.5x), Haleon (13.6x), Reckitt Benckiser (12.6x), The Clorox Company (12.3x), The Procter & Gamble Company (15.8x), and Unilever PLC (14.0x).
• K-C's Implied Enterprise Value / Estimated 2026 EBITDA is 11.2x, also below the median of 13.6x for the same comparable set.
• Analyst price targets for Kenvue common stock ranged from $15.00 to $24.50 per share (median $20.00), and for K-C common stock from $113.00 to $162.00 per share (median $132.00). The implied exchange ratio range of 0.07099x to 0.18584x (adjusted for cash consideration) derived from these targets compares to the merger agreement's exchange ratio of 0.14625x.

Management Changes

Corporate Governance

Legal Proceedings

• Steinbrecher v. Kenvue Inc. et al., Case No. 25-cv-1923 (filed December 8, 2025) in the United States District Court Eastern District of Wisconsin, alleging material omissions in the preliminary joint proxy statement/prospectus and violations of Section 14(a) and 20(a) of the Securities Exchange Act of 1934 and Rule 14a-9.
• Bass v. Allison, Jr., et al., UNNC000001-26 (filed January 1, 2026) in the Superior Court of New Jersey, Union County, alleging material omissions in the Joint Proxy Statement/Prospectus and violations of the New Jersey Uniform Securities Law, negligent misrepresentation, concealment, and negligence under New Jersey common law.
• Jones v. Kenvue Inc. et al., Index No. 650124/2026 (filed January 7, 2026) in the Supreme Court of the State of New York, alleging material omissions in the Joint Proxy Statement/Prospectus and asserting claims for negligent misrepresentation, concealment, and negligence under New York law.
• Kent v. Kenvue Inc. et al., Index No. 650178/2026 (filed January 8, 2026) in the Supreme Court of the State of New York, alleging material omissions in the Joint Proxy Statement/Prospectus and asserting claims for negligent misrepresentation, concealment, and negligence under New York law.
• Reese v. Burwell, et al., Case No. 2025-1493 (filed December 29, 2025) in the Court of Chancery of the State of Delaware, against members of the board of directors of K-C, with K-C as nominal defendant, alleging breach of fiduciary duties by failing to disclose all material information necessary for K-C stockholders to make an informed decision regarding the Mergers.
• Demand letters from purported Kenvue and K-C stockholders generally alleging material omissions or misstatements in the disclosures and demanding corrective disclosures prior to the special meetings.

Related Party Transactions

• J.P. Morgan and its affiliates had commercial and investment-banking relationships with K-C and Kenvue/its current or former affiliates in the two years preceding the opinion date, for which they received customary compensation.
• J.P. Morgan acted as joint lead arranger and joint lead bookrunner on a K-C credit facility in May 2025.
• J.P. Morgan acted as joint lead bookrunner on an offering of Kenvue equity securities in May 2024 and as passive bookrunner on an offering of Kenvue debt securities in February 2025.
• J.P. Morgan's commercial banking affiliate is an agent bank and a lender under Kenvue's outstanding credit facilities.
• Aggregate fees recognized by J.P. Morgan from Kenvue and/or its current or former affiliates were approximately $24.0 million, and from K-C were approximately $11.0 million, during the two years preceding the opinion date.
• J.P. Morgan anticipates arranging and/or providing financing to K-C in connection with the proposed transaction, expecting to receive aggregate fees of approximately $23.4 million for such services.
• Kirkland & Ellis (Kirkland) has an ongoing representation of Kenvue and certain of its former affiliates on various product liability litigation, which accounted for less than 1.0% of Kirkland's aggregate revenue for calendar year 2025 and the preceding 12-month period. This was disclosed to the K-C board and management.
• Gibson Dunn & Crutcher LLP (Gibson) was engaged by K-C as independent outside legal counsel to assist with due diligence on Kenvue product liability matters, specifically due to Kirkland's ongoing representation of Kenvue.

Stakeholder Impact

• **Shareholders (Kenvue & K-C):** Directly impacted by the merger vote and the outcome of the litigation, which seeks to ensure they have all material information to make an informed decision. The merger consideration and future combined company performance are key considerations.
• **Employees (Kenvue & K-C):** Potential for disruption to ongoing business operations and diversion of management's time due to the merger and litigation. There is also a risk to retaining key personnel.
• **Customers & Suppliers (Kenvue & K-C):** The merger and associated integration risks could adversely affect the ability to retain key customers and suppliers.
• **Creditors (Kenvue & K-C):** The combined company's indebtedness and credit ratings are a factor, with J.P. Morgan involved in financing the transaction.

Next Steps

• Kenvue and K-C stockholders are scheduled to vote on merger-related proposals at special meetings on January 29, 2026.
• There is a potential for additional similar complaints or amended complaints to be filed.
• Kenvue does not intend to announce the filing or receipt of each additional similar complaint or demand letter unless required by law.

Key Dates

Recommendation

The filing primarily provides supplemental disclosures to a merger proxy statement, addressing shareholder litigation and updating financial analyses. While the litigation introduces uncertainty and potential delays, the company is taking steps to address it. The core merger terms and strategic rationale remain unchanged, and the Kenvue board continues to unanimously recommend the transaction. Investors should hold while awaiting the outcome of the shareholder vote and the resolution of the litigation, as the fundamental value proposition of the merger is not significantly altered by these procedural updates, though the risks of delay or termination are highlighted.

Keywords

Merger, Acquisition, Kenvue, Kimberly-Clark, SEC Filing, Proxy Statement, Shareholder Litigation, Corporate Governance, Financial Analysis, Consumer Health, Personal Care